These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31095544)

  • 1. Dispensing of medication for alcohol use disorder; an examination of large databases in a New Zealand context.
    Beaglehole B; Foulds J; Mulder RT; Boden JM
    N Z Med J; 2019 May; 132(1495):48-53. PubMed ID: 31095544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone and Disulfiram Treatment Response in Veterans With Alcohol Dependence and Co-Occurring Problem-Gambling Features.
    Grant JE; Potenza MN; Kraus SW; Petrakis IL
    J Clin Psychiatry; 2017; 78(9):e1299-e1306. PubMed ID: 29345864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of dispensed disulfiram and naltrexone for alcoholism treatment in a veteran patient population.
    Hermos JA; Young MM; Gagnon DR; Fiore LD
    Alcohol Clin Exp Res; 2004 Aug; 28(8):1229-35. PubMed ID: 15318122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Ralevski E; Rounsaville B
    Biol Psychiatry; 2006 Oct; 60(7):777-83. PubMed ID: 17008146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
    Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
    J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders.
    Ralevski E; Ball S; Nich C; Limoncelli D; Petrakis I
    Am J Addict; 2007; 16(6):443-9. PubMed ID: 18058408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for alcohol misuse in correctional settings: A systematic review.
    Slavin-Stewart C; Minhas M; Turna J; Brasch J; Olagunju AT; Chaimowitz G; MacKillop J
    Alcohol Clin Exp Res; 2022 Jan; 46(1):13-24. PubMed ID: 34825363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of pharmacological therapy with acamprosate, naltrexone, and disulfiram--a systematic review].
    Petrov I; Krogh J; Nordentoft M
    Ugeskr Laeger; 2011 Nov; 173(48):3103-9. PubMed ID: 22118653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological treatment of alcohol dependence.
    Swift RM
    Med Health R I; 1997 Mar; 80(3):91-3. PubMed ID: 9117944
    [No Abstract]   [Full Text] [Related]  

  • 15. Socioeconomic and geographic disparities in access to pharmacotherapy for alcohol dependence.
    Morley KC; Logge W; Pearson SA; Baillie A; Haber PS
    J Subst Abuse Treat; 2017 Mar; 74():23-25. PubMed ID: 28132696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anesthetic considerations in a patient taking disulfiram and naltrexone for chronic alcoholism].
    del Blanco Narciso BB; Orts Castro A; Calvo Vecino JM
    Rev Esp Anestesiol Reanim; 2011 Feb; 58(2):128-9. PubMed ID: 21427831
    [No Abstract]   [Full Text] [Related]  

  • 17. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence.
    De Sousa A; De Sousa A
    Alcohol Alcohol; 2004; 39(6):528-31. PubMed ID: 15525790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' opinions about medications to treat alcoholism.
    Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
    Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone in alcohol dependence.
    Brewer C
    Lancet; 1995 Nov; 346(8986):1374. PubMed ID: 7475809
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacotherapy for Adults with Alcohol Use Disorder.
    Salisbury-Afshar E
    Am Fam Physician; 2016 Jul; 94(2):155-7. PubMed ID: 27419333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.